James Hardie (JHX) jumps 8.4% as investors refocus on guidance, AZEK integration, and the next earnings catalyst

James Hardie Industries plc (JHX) is up 8.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The day’s move looks most consistent with a sentiment-driven rebound in a housing-exposed name, with investors refocusing on James Hardie’s previously raised FY26 outlook and the longer-term earnings power expected from the AZEK combination. With the next earnings date approaching, positioning and short-covering can also amplify gains even without a single headline catalyst.

Details:

James Hardie’s most recent major outlook update included raising FY26 net sales and adjusted EBITDA guidance after reporting Q2 FY26 results, helped by the AZEK acquisition and early integration progress.

The company has framed integration and synergy capture as a key earnings driver, with cost actions and cross-selling opportunities expected to build over time.

Sell-side estimate updates have been active in recent weeks, including a notable April 8, 2026 price-target reduction by Barclays, which can set up sharp counter-moves when trading becomes crowded.

Market attention may be building ahead of the next scheduled earnings release (listed for May 18, 2026), which can pull forward buying interest in cyclical names.

Sources:

James Hardie Investor Relations, Stock Analysis, ChartMill

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$JHX Hedge Fund Activity

We have seen 144 institutional investors add shares of $JHX stock to their portfolio, and 148 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

LONG POND CAPITAL, LP removed 7,247,811 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $150,392,078
CITADEL ADVISORS LLC added 6,192,167 shares (+439.2%) to their portfolio in Q4 2025, for an estimated $128,487,465
D1 CAPITAL PARTNERS L.P. added 5,404,866 shares (+28.4%) to their portfolio in Q4 2025, for an estimated $112,150,969
JACOBS LEVY EQUITY MANAGEMENT, INC added 3,736,368 shares (+inf%) to their portfolio in Q4 2025, for an estimated $77,529,636
SLATE PATH CAPITAL LP added 3,083,434 shares (+135.2%) to their portfolio in Q4 2025, for an estimated $63,981,255
RDST CAPITAL LLC added 2,693,617 shares (+inf%) to their portfolio in Q4 2025, for an estimated $55,892,552
RENAISSANCE TECHNOLOGIES LLC added 2,585,089 shares (+inf%) to their portfolio in Q4 2025, for an estimated $53,640,596

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$JHX Analyst Ratings

Wall Street analysts have issued reports on $JHX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Baird issued a "Outperform" rating on 11/19/2025
Oppenheimer issued a "Outperform" rating on 11/19/2025
Citigroup issued a "Buy" rating on 11/04/2025

To track analyst ratings and price targets for $JHX, check out Quiver Quantitative's $JHX forecast page.

$JHX Price Targets

Multiple analysts have issued price targets for $JHX recently. We have seen 4 analysts offer price targets for $JHX in the last 6 months, with a median target of $28.0.

Here are some recent targets:

Matthew Bouley from Barclays set a target price of $22.0 on 04/08/2026
Keith Hughes from Truist Securities set a target price of $30.0 on 02/11/2026
Timothy Wojs from Baird set a target price of $26.0 on 11/19/2025
Tyler Batory from Oppenheimer set a target price of $30.0 on 11/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.